# Zymeworks Inc.: filings

ZYME · Nasdaq · CIK 1937653 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zyme.md) · [Financials](/companies/zyme/financials.md) · [Filings](/companies/zyme/filings.md) · [Insiders](/companies/zyme/insiders.md)

## Reports and events: 111 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 94, 8-K 79, 144 22, 3 21, SC 13G/A 13, 10-Q 12, 424B5 8, SCHEDULE 13D/A 6, SCHEDULE 13G/A 6, 425 5, DEF 14A 5, DEFA14A 5, S-8 5, SC 13G 5, 10-K 4, 4/A 4, S-8 POS 4, ARS 3, CORRESP 2, EFFECT 2, POSASR 2, S-3ASR 2, SC 13D/A 2, 10-K/A 1, 25 1, 424B3 1, 8-A12B 1, 8-A12B/A 1, 8-K12B 1, CERT 1, D 1, POS AM 1, PRE 14A 1, RW 1, S-3 1, S-4 1, S-4/A 1, S-4MEF 1, SC 13D 1, SCHEDULE 13D 1, SCHEDULE 13G 1, UPLOAD 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 16:11 ET | [DEF 14A](/filings/0001193125-26-431936.md) | Proxy statement, period 2026-12-15 | 0001193125-26-431936 |
| 2026-10-23 | 06:07 ET | [8-K](/filings/0001937653-26-000055.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-26-000055 |
| 2026-09-23 | 16:06 ET | [8-K](/filings/0001193125-26-399383.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-399383 |
| 2026-08-25 | 10:54 ET | [8-K](/filings/0001937653-26-000051.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001937653-26-000051 |
| 2026-08-06 | 16:11 ET | [10-Q](/filings/0001937653-26-000047.md) | Quarterly report, period 2026-06-30 | 0001937653-26-000047 |
| 2026-08-06 | 16:09 ET | [8-K](/filings/0001937653-26-000046.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-26-000046 |
| 2026-06-29 | 07:20 ET | [8-K](/filings/0001193125-26-286829.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-286829 |
| 2026-05-14 | 16:29 ET | [8-K](/filings/0001193125-26-224161.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-224161 |
| 2026-05-07 | 16:15 ET | [10-Q](/filings/0001937653-26-000034.md) | Quarterly report, period 2026-03-31 | 0001937653-26-000034 |
| 2026-05-07 | 16:10 ET | [8-K](/filings/0001937653-26-000033.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-26-000033 |
| 2026-04-01 | 06:16 ET | [8-K](/filings/0001193125-26-135610.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-135610 |
| 2026-03-02 | 06:28 ET | [8-K](/filings/0001193125-26-084082.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-084082 |
| 2026-03-02 | 06:28 ET | [10-K](/filings/0001937653-26-000015.md) | Annual report, period 2025-12-31 | 0001937653-26-000015 |
| 2026-03-02 | 06:03 ET | [8-K](/filings/0001937653-26-000013.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-26-000013 |
| 2026-01-12 | 16:34 ET | [8-K](/filings/0001193125-26-010480.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-010480 |
| 2025-12-30 | 17:11 ET | [8-K](/filings/0001193125-25-337268.md) | 5.07 Shareholder vote results | 0001193125-25-337268 |
| 2025-11-19 | 17:39 ET | [SCHEDULE 13D/A](/filings/0000935836-25-000711.md) | Ownership report, active investor, amended | 0000935836-25-000711 |
| 2025-11-18 | 06:03 ET | [8-K](/filings/0001193125-25-285259.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-285259 |
| 2025-11-17 | 06:13 ET | [8-K](/filings/0001193125-25-283873.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-283873 |
| 2025-11-10 | 16:24 ET | [DEF 14A](/filings/0001193125-25-274338.md) | Proxy statement, period 2025-12-30 | 0001193125-25-274338 |
| 2025-11-06 | 16:16 ET | [10-Q](/filings/0001937653-25-000077.md) | Quarterly report, period 2025-09-30 | 0001937653-25-000077 |
| 2025-11-06 | 16:08 ET | [8-K](/filings/0001937653-25-000076.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-25-000076 |
| 2025-09-02 | 06:58 ET | [8-K](/filings/0001193125-25-193351.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-193351 |
| 2025-08-11 | 08:30 ET | [8-K](/filings/0001193125-25-177505.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-177505 |
| 2025-08-07 | 16:20 ET | [10-Q](/filings/0001937653-25-000049.md) | Quarterly report, period 2025-06-30 | 0001937653-25-000049 |
| 2025-08-07 | 16:09 ET | [8-K](/filings/0001937653-25-000047.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-25-000047 |
| 2025-06-27 | 18:14 ET | [SCHEDULE 13D](/filings/0000935836-25-000439.md) | Ownership report, active investor | 0000935836-25-000439 |
| 2025-06-27 | 16:15 ET | [8-K](/filings/0001193125-25-151279.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-151279 |
| 2025-05-30 | 17:14 ET | [8-K](/filings/0001193125-25-132299.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-132299 |
| 2025-05-08 | 16:11 ET | [10-Q](/filings/0001937653-25-000027.md) | Quarterly report, period 2025-03-31 | 0001937653-25-000027 |
| 2025-05-08 | 16:08 ET | [8-K](/filings/0001937653-25-000026.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-25-000026 |
| 2025-04-08 | 16:24 ET | [SCHEDULE 13D/A](/filings/0000935836-25-000268.md) | Ownership report, active investor, amended | 0000935836-25-000268 |
| 2025-03-17 | 19:50 ET | [SCHEDULE 13D/A](/filings/0000935836-25-000230.md) | Ownership report, active investor, amended | 0000935836-25-000230 |
| 2025-03-05 | 16:12 ET | [10-K](/filings/0001937653-25-000014.md) | Annual report, period 2024-12-31 | 0001937653-25-000014 |
| 2025-03-05 | 16:08 ET | [8-K](/filings/0001937653-25-000012.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-25-000012 |
| 2025-02-18 | 18:25 ET | [SCHEDULE 13D/A](/filings/0000935836-25-000186.md) | Ownership report, active investor, amended | 0000935836-25-000186 |
| 2025-02-18 | 06:19 ET | [8-K](/filings/0001193125-25-028050.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028050 |
| 2025-01-13 | 19:18 ET | [SCHEDULE 13D/A](/filings/0000935836-25-000060.md) | Ownership report, active investor, amended | 0000935836-25-000060 |
| 2025-01-08 | 16:16 ET | [8-K](/filings/0001193125-25-003519.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-003519 |
| 2024-12-23 | 19:54 ET | [SCHEDULE 13D/A](/filings/0000935836-24-000776.md) | Ownership report, active investor, amended | 0000935836-24-000776 |
| 2024-12-11 | 16:05 ET | [8-K](/filings/0001193125-24-275534.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-24-275534 |
| 2024-11-21 | 16:07 ET | [8-K](/filings/0001193125-24-263398.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-263398 |
| 2024-10-31 | 16:12 ET | [10-Q](/filings/0001937653-24-000050.md) | Quarterly report, period 2024-09-30 | 0001937653-24-000050 |
| 2024-10-31 | 16:11 ET | [8-K](/filings/0001937653-24-000049.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-24-000049 |
| 2024-10-29 | 16:06 ET | [DEF 14A](/filings/0001193125-24-246527.md) | Proxy statement, period 2024-12-10 | 0001193125-24-246527 |
| 2024-10-18 | 16:06 ET | [8-K](/filings/0001193125-24-239630.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-24-239630 |
| 2024-09-03 | 16:06 ET | [8-K](/filings/0001193125-24-212062.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-212062 |
| 2024-08-02 | 07:10 ET | [8-K](/filings/0001193125-24-192058.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-192058 |
| 2024-08-01 | 16:18 ET | [8-K](/filings/0001193125-24-191535.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-191535 |
| 2024-08-01 | 16:13 ET | [10-Q](/filings/0001937653-24-000041.md) | Quarterly report, period 2024-06-30 | 0001937653-24-000041 |

Page 1 of 3. [Older](/companies/zyme/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:15 ET. No prices; not investment advice.